- Filed
- Oct 28, 2021 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2022 · Oct 22, 2021 | 45.5M sh |
| Cash And Equivalents | Q2 2022 · Sep 30, 2021 | $241.88M |
| Cash And Equivalents | Q2 2022 · Mar 31, 2021 | $232.71M |
| Current Liabilities | Q2 2022 · Sep 30, 2021 | $114.02M |
| Current Liabilities | Q2 2022 · Mar 31, 2021 | $128.97M |
| Total Liabilities | Q2 2022 · Sep 30, 2021 | $145.47M |
| Total Liabilities | Q2 2022 · Mar 31, 2021 | $164.68M |
| Current Assets | Q2 2022 · Sep 30, 2021 | $871.49M |
| Current Assets | Q2 2022 · Mar 31, 2021 | $787.97M |
| Total Assets | Q2 2022 · Sep 30, 2021 | $1.53B |
| Total Assets | Q2 2022 · Mar 31, 2021 | $1.49B |
| Shares Diluted | Q2 2022 · Sep 30, 2020 | 45.66M sh |
| Shares Diluted | Q2 2022 · Sep 30, 2020 | 45.61M sh |
| Stock Repurchased | Q2 2022 · Sep 30, 2020 | $11.31M |
| Capex | Q2 2022 · Sep 30, 2020 | $19.55M |
| Operating Cash Flow | Q2 2022 · Sep 30, 2020 | $108.97M |
| Stockholders Equity | Q2 2022 · Sep 30, 2020 | $1.18B |
| Stockholders Equity | Q2 2022 · Jun 30, 2020 | $1.1B |
| Stockholders Equity | Q2 2022 · Mar 31, 2020 | $1.07B |
| Eps Diluted | Q2 2022 · Sep 30, 2020 | $1.36 |
| Eps Diluted | Q2 2022 · Sep 30, 2020 | $2.34 |
| Eps Basic | Q2 2022 · Sep 30, 2020 | $1.38 |
| Eps Basic | Q2 2022 · Sep 30, 2020 | $2.37 |
| Sga Expense | Q2 2022 · Sep 30, 2020 | $79.17M |
| Sga Expense | Q2 2022 · Sep 30, 2020 | $147.61M |
| Rd Expense | Q2 2022 · Sep 30, 2020 | $30.53M |
| Rd Expense | Q2 2022 · Sep 30, 2020 | $56.88M |
| Net Income | Q2 2022 · Sep 30, 2020 | $62.21M |
| Net Income | Q2 2022 · Sep 30, 2020 | $106.8M |
| Net Income | Q2 2022 · Jun 30, 2020 | $44.59M |
| Operating Income | Q2 2022 · Sep 30, 2020 | $61.34M |
| Operating Income | Q2 2022 · Sep 30, 2020 | $95.4M |
| Revenue | Q2 2022 · Sep 30, 2020 | $209.76M |
| Revenue | Q2 2022 · Sep 30, 2020 | $374.61M |